what is biosimilar interchangeability

Biosimilar interchangeability is an FDA designation allowing a biosimilar to be substituted for its reference biologic at the pharmacy without prescriber approval. It requires additional evidence showing the same clinical result and no greater risk when patients switch between products, per the FDA’s Biologics Price Competition and Innovation Act.